Quick Search
-
Barriers to achieving a cure in lymphoma
Review|Published on: 5 Nov 2021
Articles See more
-
Overcoming drug resistance by targeting protein homeostasis in multiple myeloma
Review|Published on: 2 Dec 2021
-
EGFR/BRAF/MEK co-inhibition for EGFR-mutated lung adenocarcinoma patients with an acquired BRAFV600E mutation: a case report and review of literature
Case Report|Published on: 1 Dec 2021
-
Gene expression profiling as a prognostic tool in multiple myeloma
Review|Published on: 1 Dec 2021
-
Adjuvant role of a T-type calcium channel blocker, TTA-A2, in lung cancer treatment with paclitaxel
Original Article|Published on: 14 Nov 2021
-
Targeting of PI3K/AKT signaling and DNA damage response in acute myeloid leukemia: a novel therapeutic strategy to boost chemotherapy response and overcome resistance
Mini Review|Published on: 10 Nov 2021
-
Barriers to achieving a cure in lymphoma
Review|Published on: 5 Nov 2021
-
Cellular irinotecan resistance in colorectal cancer and overcoming irinotecan refractoriness through various combination trials including DNA methyltransferase inhibitors: a review
Review|Published on: 2 Nov 2021
-
Overview of microRNAs as liquid biopsy biomarkers for colorectal cancer sub-type profiling and chemoresistance
Review|Published on: 26 Oct 2021
-
The HGF/c-MET axis as a potential target to overcome survival signals and improve therapeutic efficacy in multiple myeloma
Review|Published on: 21 Oct 2021
-
SF3B1 modulators affect key genes in metastasis and drug influx: a new approach to fight pancreatic cancer chemoresistance
Original Article|Published on: 8 Oct 2021
-
Expression of histone deacetylase (HDAC) family members in bortezomib-refractory multiple myeloma and modulation by panobinostat
Original Article|Published on: 23 Sep 2021
-
Recent advances in tumor-targeting chemotherapy drugs
Editorial|Published on: 8 Sep 2021
-
Overcoming acquired chemo-resistance to gemcitabine: implications from the perspective of multi-modal therapy including surgery for pancreatic cancer
Commentary|Published on: 7 Sep 2021
-
The aqueous extract of brucea javanica reduces tumorigenicity of human lung cancer tumorspheres
Original Article|Published on: 13 Aug 2021
-
MYC inhibitors in multiple myeloma
Review|Published on: 13 Aug 2021
Most Cited Papers In Last Two Years See more
-
MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolution
Review|Published on: 19 Dec 2019 -
Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors
Review|Published on: 19 Sep 2019
-
The role of exosomal long non-coding RNAs in cancer drug resistance
Review|Published on: 19 Dec 2019
Ongoing Special Issues See more
-
Topic: Resistance to Anti-Angiogenic Therapy in Cancer
Submission Deadline: 30 Jun 2022
Published articles: 0
-
Topic: Nanotechnology Applied to Overcome Tumor Drug Resistance
Submission Deadline: 30 Jun 2022
Published articles: 0
-
Topic: Novel Targets for Therapy Resistant Pancreatic Carcinoma
Submission Deadline: 30 Apr 2022
Published articles: 1
-
Topic: Papers from The SOHO (Society of Hematologic Oncology) 3rd Italian Conference
Submission Deadline: 30 Apr 2022
Published articles: 0
-
Topic: Targeting Signaling Pathway to Overcome Drug Resistance for Cancer Therapy
Submission Deadline: 31 Mar 2022
Published articles: 0
-
Topic: Papers from the 2nd BACR Conference "Response and Resistance in Cancer Therapy"
Submission Deadline: 31 Mar 2022
Published articles: 0
-
Topic: Molecular Mechanisms of Targeted Therapy Resistance in Breast Cancers
Submission Deadline: 28 Feb 2022
Published articles: 0
-
Topic: DNA Repair & Metabolism and Cancer Drug Resistance
Submission Deadline: 28 Feb 2022
Published articles: 1
-
-
Topic: Cell Cycle-based Therapies to Overcome Chemoresistance
Submission Deadline: 31 Dec 2021
Published articles: 0
-
Topic: Tumor Microenvironment and Drug Resistance
Submission Deadline: 31 Dec 2021
Published articles: 0
-
Topic: Memory of Franco Muggia：Drug Resistance in Female Cancer
Submission Deadline: 31 Dec 2021
Published articles: 1
-
Topic: The Role of the Microbiome in Drug Resistance
Submission Deadline: 31 Dec 2021
Published articles: 0
-
Topic: Research Progress on Drug Resistance in Acute Myeloid Leukemia
Submission Deadline: 30 Oct 2021
Published articles: 0
-
Topic: Drug Resistance in Metastatic Castration-Resistant Prostate Cancer
Submission Deadline: 1 Oct 2021
Published articles: 0
-
-
Topic: Circulating Biomarkers: Prospects in Cancer Drug Resistance
Submission Deadline: 20 Sep 2021
Published articles: 0
-
Topic: Advanced Research of Drug Resistance in Soft Tissue and Bone Sarcoma
Submission Deadline: 31 Aug 2021
Published articles: 0
-
Topic: Drug Targets and Resistance Mechanisms in Multiple Myeloma
Submission Deadline: 31 Jul 2021
Published articles: 4
-
Topic: Drug Resistance and New Therapies in Colorectal Cancer
Submission Deadline: 30 Jun 2021
Published articles: 2
-
Topic: Research Progress on Drug Resistance in Lymphomas
Submission Deadline: 30 Apr 2021
Published articles: 3
-
Topic: Mechanism and Detection of Acquired Drug Resistance in Cancer therapy
Submission Deadline: 31 Mar 2021
Published articles: 4
Special Issue Ebooks See more
.jpg)
About The Journal
-
ISSN
2578-532X (Online)
Publisher
OAE Publishing Inc.
Article Processing Charges
$1200
-
Editor-in-Chief
Godefridus J. PetersPublishing Model
Gold Open Access
Copyright
Copyright is retained by author(s)
-
Publication Frequency
Quarterly
Indexing
Journal Data Analysis
Total publications: 242
Total article views: 753,058
Total article downloads: 119,681
Open Archives
-
Portico
All published articles will be preserved here permanently:
https://www.portico.org/
